Olink Holding AB (NAS:OLK)
$ 24.03 0.08 (0.33%) Market Cap: 2.99 Bil Enterprise Value: 2.90 Bil PE Ratio: 0 PB Ratio: 6.48 GF Score: 60/100

Olink Holding AB (publ) at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 02:00PM GMT
Release Date Price: $13.11 (-2.02%)
Unidentified Analyst

Good morning, everyone. Welcome to day 3 of the JPMorgan Healthcare Conference. This is [Julia Ching] from Life Science team at JPMorgan, and it's my great pleasure to introduce you to our next company presentation by Olink.

Just as a reminder, if you have a question, you can submit it through the website. And with that, let me turn it over to Jon.

Jon Heimer;publ;CEO;Director
Olink Holding AB

()-&

Thank you very much, Julia, and good morning, everyone. Firstly, I want to thank our dear friends at JPMorgan inviting me to present here today. I really look forward to meeting all of you in person and have planned for an in-person event, but very much appreciate the invitation and the opportunity to speak with everyone here today.

My name is Jon Heimer. This year, I complete 30 years as a serial entrepreneur in the biotech device and drug development space. I was part of founding Olink in 2016 and been its CEO since inception.

I reminded to everyone today that I'll be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot